Improving pancreatic cancer screening using advanced ultrasound techniques
Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization
This study is testing a new way to use ultrasound to help find pancreatic cancer earlier and more accurately, especially for people who are at higher risk, so that they can get better treatment options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11034663 on NIH RePORTER |
What this research studies
This research focuses on enhancing the screening and characterization of pancreatic cancer through a novel multiparametric endoscopic ultrasound (mpEUS) approach. It aims to develop a comprehensive imaging system that combines various ultrasound techniques to better evaluate pancreatic tissue, particularly for high-risk individuals. By utilizing advanced imaging modalities, the study seeks to identify early-stage pancreatic cancer and precursors that could lead to cancer, thereby improving early detection and treatment options for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with specific genetic syndromes or familial predispositions that increase their risk of developing pancreatic cancer.
Not a fit: Patients without a family history of pancreatic cancer or those not classified as high-risk individuals may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of pancreatic cancer, significantly improving patient outcomes and survival rates.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer detection, indicating that this approach could yield significant advancements in pancreatic cancer screening.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Burgess, Mark Thomas — Sloan-Kettering Inst Can Research
- Study coordinator: Burgess, Mark Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.